GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bullfrog AI Holdings Inc (NAS:BFRG) » Definitions » Cash Flow from Financing

Bullfrog AI Holdings (Bullfrog AI Holdings) Cash Flow from Financing : $7.13 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Bullfrog AI Holdings Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2024, Bullfrog AI Holdings received $5.68 Mil more from issuing new shares than it paid to buy back shares. It received $0.51 Mil from issuing more debt. It paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.00 Mil from paying cash dividends to shareholders. It received $0.11 Mil on other financial activities. In all, Bullfrog AI Holdings earned $6.29 Mil on financial activities for the three months ended in Mar. 2024.


Bullfrog AI Holdings Cash Flow from Financing Historical Data

The historical data trend for Bullfrog AI Holdings's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bullfrog AI Holdings Cash Flow from Financing Chart

Bullfrog AI Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Cash Flow from Financing
0.21 0.39 0.97 8.57

Bullfrog AI Holdings Quarterly Data
Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.72 1.27 -0.21 -0.21 6.29

Bullfrog AI Holdings Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Bullfrog AI Holdings's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

Bullfrog AI Holdings's Cash from Financing for the quarter that ended in Mar. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bullfrog AI Holdings  (NAS:BFRG) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Bullfrog AI Holdings's issuance of stock for the three months ended in Mar. 2024 was $5.68 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Bullfrog AI Holdings's repurchase of stock for the three months ended in Mar. 2024 was $0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Bullfrog AI Holdings's net issuance of debt for the three months ended in Mar. 2024 was $0.51 Mil. Bullfrog AI Holdings received $0.51 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Bullfrog AI Holdings's net issuance of preferred for the three months ended in Mar. 2024 was $0.00 Mil. Bullfrog AI Holdings paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Bullfrog AI Holdings's cash flow for dividends for the three months ended in Mar. 2024 was $0.00 Mil. Bullfrog AI Holdings received $0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Bullfrog AI Holdings's other financing for the three months ended in Mar. 2024 was $0.11 Mil. Bullfrog AI Holdings received $0.11 Mil on other financial activities.


Bullfrog AI Holdings Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Bullfrog AI Holdings's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Bullfrog AI Holdings (Bullfrog AI Holdings) Business Description

Traded in Other Exchanges
N/A
Address
325 Ellington Boulevard, Unit 317, Gaithersburg, MD, USA, 20878
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.
Executives
William Enright director 910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG MD 20878
R Don Elsey director 2273 RESEARCH BLVD, SUITE 400, ROCKVILLE MD 20850
Dane R Saglio officer: Chief Financial Officer
Jason David Hanson director 8125 NORTH HAYDEN ROAD, SCOTTSDALE AZ 85258-2463
Vininder Singh director, 10 percent owner, officer: Chief Executive Officer 4 BLACK KETTLE COURT, BOYDS MD 20841